Usted buscó: ankilozuojancio (Lituano - Inglés)

trudexa vartojamas suaugusij sunkaus aktyvaus ankilozuojancio spondilito gydymui tada, kai ist
trudexa is indicated for the treatment of adults with severe active ankylosing spondylitis who have dic

piroksikamo skiriama reumatoidinio artrito, osteoartrito ar ankilozuojancio spondilito simptominiam gydymui.
indications regarding osteoarthritis, rheumatoid arthritis and ankylosing spondylitis should read as follows:" piroxicam is indicated for symptomatic relief of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis.

humira vartojamas suaugusij sunkaus aktyvaus ankilozuojancio spondilito gydymui tada, kai atsakas prastin gydym yra nepakankamas.
humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.

trudexa vartojamas suaugusij sunkaus aktyvaus ankilozuojancio spondilito gydymui tada, kai atsakas prastin gydym yra nepakankamas.va
trudexa is indicated for the treatment of adults with severe active ankylosing spondylitis who have i

trudexa vartojusiems pacientams simptomai reiksmingai labiau palengvjo 12 savait ir sis atsakas isliko iki 24 savaits ir pagal sf36, ir pagal ankilozuojancio spondilito gyvenimo kokybs klausimyn
trudexa treated patients had significantly greater improvement at week 12 which was maintained

trudexa, skiriamas nuo ankilozuojancio spondilito ir vartojamas kaip papildomasis vaistas gydant kitu vaistu, buvo lyginamas su placebu dviejuose tyrimuose, kuriuose dalyvavo 397 pacientai.
for ankylosing spondylitis, trudexa and placebo as an add-on to existing treatment were compared in two studies involving 397 patients.

ankilozuojancio spondilito atveju dviej tyrim metu (kuriuose dalyvavo 397 pacientai) buvo lyginamas humira ir anksciau skirto vaisto derinio bei placebo ir anksciau skirto vaisto derinio poveikis.
for ankylosing spondylitis, humira and placebo as an add-on to existing treatment were compared in two studies involving 397 patients.

a ankilozuojancio spondilito vertinimo skal (assessments in ankylosing spondylitis) b bath ankilozuojancio spondilito ligos aktyvumo indeksas (bath ankylosing spondylitis disease activity index) rep
tho a assessments in ankylosing spondylitis b bath ankylosing spondylitis disease activity index

18 didesnio tyrimo (viii) , kuriame dalyvavo 315 pacient, rezultatai rodo, kad humira gydytiems pacientams statistiskai reiksmingai palengvjo ankilozuojancio spondilito simptomai lyginant su placebo gavusia grupe.
in the larger study (viii) with 315 patients, results showed statistically significant improvement of the signs and symptoms of ankylosing spondylitis in patients treated with humira compared to placebo.

jeigu sergate ankilozuojanciu spondilitu, jums pirmiausia paskirs kit vaist.
if you have ankylosing spondylitis you will first be given other medicines.